NNI Releases Supplement to the President’s 2016 Budget
Budget provides $1.5 billion in funding; details progress on NSIs, collaborations between Federal agencies
The President’s Budget for Fiscal Year 2016 provides $1.5 billion for the National Nanotechnology Initiative (NNI), a continued Federal investment in support of the President’s priorities and innovation strategy. Cumulatively totaling more than $22 billion since the inception of the NNI in 2001, this funding reflects nanotechnology’s potential to significantly improve our fundamental understanding and control of matter at the nanoscale and to translate that knowledge into solutions for critical national needs.
Nearly half of the requested budget is dedicated to applications-focused R&D and support for the Nanotechnology Signature Initiatives (NSIs), reflecting an increased
“Right now, the NNI is focused on innovations that support national priorities, while maintaining a strong foundation of fundamental research in nanoscience,” says Dr. Michael Meador, Director of the National Nanotechnology Coordination Office. “Our goal is to
The President’s 2016 Budget supports nanoscale science, engineering, and technology R&D at 11 agencies; another 9 agencies have nanotechnology-related mission interests or regulatory responsibilities. The NNI Supplement to the President’s 2016 Budget documents activities of these agencies in addressing the goals and objectives of the NNI.
To view the full document, visit www.nano.gov/
Marlowe Newman, Communications
The NanoBCA is honored to have the National Nanotechnology Coordination Office’s (NNCO) newly appointed Director, Dr.
– Stephen (Steve) B. Maebius, IP Partner & Nanotech Team Member,
– Dr. Gilberto M. (Ybet) Villacorta, Intellectual Property Department
– Doyle Edwards, Director, Government Programs, Brewer Science
– Scott Rickert, Chairman & CEO, PEN Inc.
– David Arthur, CEO, SouthWest NanoTechnologies Inc. (SWeNT)
– Max Atanasov, CEO, OCSiAl LLC
– Scott Livingston, Chairman & CEO, Livingston Securities LLC
– Anil R. Diwan, Ph.D., President & Chairman, NanoViricides, Inc.
– Jim Phillips, Chairman/CEO, NanoMech
– Craig Bandes, CEO, Pixelligent Technologies, LLC
– Carleton Hsia, Ph.D., Chairman & CEO, NanoBlood LLC
– Mark Shaw, CEO, Ultratech, Inc.
– Ronald Durando, Chariman, President & CEO, mPhase Technologies,
– Frank Adell, CEO, Pharmaco-Kinesis Corporation
May 19-20 in Washington, DC
We will be meeting with representatives from the White House Office of Science & Technology Policy (OSTP) on the second day of our event (Wednesday, May 20th). There will be a panel discussion with members of Nanotechnology leaders such as:
– Lynn L. Bergeson, Managing Partner, Bergeson & Campbell PC
– Doug Jamison, Chairman of the Board, CEO & Managing Director,
– Jess Jankowski, President & CEO, Nanophase Technologies Corp.
– Chuck Van Fleet, President, Swan Chemical
– Matthew Putman, Ph.D., CEO, Nanotronics Imaging
– Glenn Kerner, Chair of the Nanotechnology Practice, Goodwin Procter
– Nilda Isidro, Partner, Food & Beverage & Products Liability
– John Bender, Chief Operating Officer, agencyIP
– Philip H. Lippel, Ph.D., Assistant Director, MIT Washington Office
– Sam Brauer, Ph.D., Principal, Nanobiz LLC
– Jeffrey Morse, Ph.D., Managing Director, National Nanomanufacturing
500 H St NW, Washington, DC 20001
888 236 2427
$299 per night (When Congress is in session, it is very expensive in Washington, DC with limited hotel availability)
When making reservations please refer to the room block name: Nano Conference
Join NanoBCA in Washington, DC, May 19-20th, to learn about the issues at hand and to meet with and be heard by the key policy makers.
NanoBusiness Commercialization Association